The ADC targets Trop-2 on the cell surface; after internalization it releases SN-38, which inhibits topoisomerase I to cause DNA damage and apoptosis. Expression of topoisomerase I alone does not lead to targeted killing; cytotoxicity depends on Trop-2–mediated delivery (with some bystander effect).